Avanir Pharmaceuticals to Participate in Two Conferences in May
ALISO VIEJO, Calif., May 1, 2014
ALISO VIEJO, Calif., May 1, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc.
(NASDAQ: AVNR) today announced that company management will present an
overview of the company at the following conferences in May.
oDeutsche Bank 39th Annual Health Care Conference
oPresentation date: Thursday, May 8, 2014
oPresentation time: 2:10 p.m. E.T.
oBank of America Merrill Lynch 2014 Health Care Conference
oPresentation date: Tuesday, May 13, 2014
oPresentation time: 1:00 p.m. P.T.
Avanir Pharmaceuticals, Inc.
A live webcast and 30-day archive of these presentations will be available at
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on
bringing innovative medicines to patients with central nervous system
disorders of high unmet medical need. As part of our commitment, we have
extensively invested in our pipeline and are dedicated to advancing medicines
that can substantially improve the lives of patients and their loved ones. For
more information about Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc.
in the United States and other countries.
^©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700
Logo - http://photos.prnewswire.com/prnh/20130207/LA55901LOGO
SOURCE Avanir Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.